On October 10,the project land of Canaan Biomedical Equipment Science and Technology Park(Tianjin)in UDA(Wuqing Development Zone)was successfully auctioned.
It is understood that the project has a land area of 40,000m2 with a total construction area of 50,000m2 and an investment intensity of 600 yuan RMB per square meters.It plans to build a biomedical equipment R&D and manufacturing base composed of six functional modules of simulation design,digital workshop,automated warehousing and logistics,product life cycle management,product intelligent service platform,and product application demonstration.It aims to build an intelligent science and technology park with a new production mode integrating R&D,simulation,production and verification.
After production,the complete production system can support the efficient and high-quality production of drugs.Meanwhile,it can provide a technical platform for the development of biopharmaceutical technology,key technologies for the creation of new chemical drugs and the research and development of injection preparation technology.It will play a positive role in promoting the development of biomedical industry agglomeration in UDA.
“The Canaan Biomedical Equipment Science and Technology Park(Tianjin)project is invested and constructed by Canaan(Tianjin)Technology Co.,Ltd.,a wholly-owned subsidiary of Zhejiang Canaan Science and Technology Co.,Ltd.The project is centered in Tianjin,relying on the markets cultivated by the headquarters for many years at home and abroad,and faces customers in North China,Northeast China,Eastern Europe,East Asia and other customer groups.It will build a smart life health industry ecology,create national research and development platform,set up advanced pharmaceutical equipment industry research institute 4.0.It will also attract industrial outstanding talents of science and technology,and develop more key technological equipment.Moreover,it advances the University-Industry-Research cooperation,cutting-edge technology study and development of new products,and actively push forward cooperation with large pharmaceutical companies in depth.The company will continue to expand the production capacity of biological equipment manufacturing,enhance the overall solution capability of bioengineering,seize the opportunity of import substitution,and further expand the company\'s business scale”the project leader said.
Next,UDA will be adhering to the idea of“serving others is to develop yourself”,provide enterprises with all-round and efficient services,and promote the project early construction,completion and full operation to finally accelerate the industrial development.
News 
Contact Us
Home